Revance Therapeutics Stock (NASDAQ: RVNC) stock price, news, charts, stock research, profile.
Open | $4.07 |
Close | $4.34 |
Volume / Avg. | 2.31M / 2.01M |
Day Range | 3.96 - 4.36 |
52 Wk Range | 2.30 - 24.87 |
Market Cap | $451.22M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 70 |
Short Interest | 16.7% |
Days to Cover | 7.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Revance Therapeutics (NASDAQ:RVNC) through any online brokerage.
Other companies in Revance Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
There is no analysis for Revance Therapeutics.
Revance Therapeutics has a consensus price target of $13.20.
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $4.32 last updated July 23, 2024 at 7:19 PM EDT.
There are no upcoming dividends for Revance Therapeutics.
Revance Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Revance Therapeutics.
Revance Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.